During Friday's early trading session, genome analysis scientific instrument company Bionano Genomics (BNGO) raised its 2025 optical genome mapping (OGM) equipment installation target to 25 units, while consumables and software revenue increased by 16%. The company reported second quarter revenue of $6.7 million and is currently focusing on supporting routine users of its optical genome mapping technology.
Bionano is driving business growth by strengthening its software product portfolio.